“R.itemList.length” “- this.config.text.ariaShown
“This.config.text.ariaFermé”
By Anthony Esposito and Adriana Barrera
MEXICO CITY, 30 Aug (Reuters) – Mexico continues its efforts to forge vaccine alliances opposed to COVID-19 in a wide ideological diversity of countries, from France to Cuba, because a World Health Organization (WHO) vaccination initiative will meet its needs.
Mexico joined WHO’s global COVAX plan in early June, which aims to deliver at least 2 billion doses of approved vaccines through the end of next year and “fair access.”
But Martha Delgado, Mexico’s deputy foreign minister who was commissioned by President Andrés Manuel López Obrador in charge of Mexico’s external response, told Reuters that her percentage of the program would probably not be enough to supply the roughly two hundred million doses of vaccines Mexicans will need.
“We can’t count on that, ” said Delgado. “COVAX promises 20% of the population: we want more vaccines and other countries as well.”
Delgado’s boss, Chancellor Marcelo Ebrard, briefed López Obrador on the latest advances in efforts to unload a vaccine, or vaccines, which will reduce mexico’s epidemic of the new coronavirus, he said, an effort that encompasses all primary superpowers and their allies.
Left-wing populist López Obrador has surprised in some quarters by forging a close alliance with U.S. President Donald Trump. But Ebrard also assiduously courted China, which provided Mexico with gadgets such as enthusiasts and masks. And López Obrador has come forward to check the Russian vaccine despite the unhook of some scientists.
The Foreign Ministry presses in an email that the “nationalism of vaccines” deserves to be rejected because “no one will be safe until everyone is safe, and that is why negotiation, international relations and multilateralism play a very important role.”
Delgado said her daily schedule is guilty of talking to fitness sector representatives, ambassadors, chancelleries, laboratories and doctors.
“We have chosen to do so through our diplomatic channels, to have pharmaceutical and data corporations through cooperation with other countries,” Delgado said.
“Why take this route? First, countries themselves will certify their vaccines, their safety, pharmaceutical companies.
“And secondly, because Mexico has diplomatic prestige,” Delgado said, pointing to a United Nations solution that effectively sponsored to make medicines, vaccines and medical devices universal to deal with COVID-19.
The strategy turns out to be working.
Mexico will participate in the clinical trials of the Italian GRAd-COV2 vaccine and agreed that 2,000 volunteers should participate in the trials of the Russian vaccine “Sputnik V”.
It also entered into an agreement to produce the vaccine from the pharmaceutical company AstraZeneca Plc. In addition, he plans to participate in Phase 3 trials with French drug manufacturer Sanofi, Johnson-Johnson’s Janssen unit and Chinese corporations CanSino Biologics Inc and Walvax Biotechnology Co Ltd, all of which have agreed to secure their vaccines if successful.
It plans to communicate to Cuba about its so-called Sovereign Vaccine 01, or Sovereign 01, and the German government of the biotechnological corporation CureVac, which is how to use messenger RNA to treat a variety of diseases, adding coronavirus.
International Mexican vaccine relations would possibly have helped Russia conduct a complex test of its vaccine, which will involve more than 40,000 people and be supervised through a foreign research organization.
The “Sputnik V”, named after the world’s first satellite introduced through the Soviet Union, was acclaimed and effective by the Russian government and scientists after two months of small-scale human testing.
But Western experts have warned that they oppose its use until the approved evidence and regulatory measures have been taken around the world.
The Russians then sought to donate vaccines to Mexicans to verify as a finished product, but Mexico first sought more data on phase 1 and 2 trials, Delgado said.
Russia now agreed to conduct 3 trials on the vaccine, some of which are taking a position in Mexico itself, he said. (Report through Anthony Esposito and Adriana Barrera; Editing via Christian Plumb, Marguerita Choy and Grant McCool)